NCT02878733 - Albumin Administration and Outcomes in Cardiac Surgery | Biotech Hunter

Enrollment

6,249

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Thoracic Surgery

Interventions

DRUG

Albumin

patients that had either received any volume of 5% albumin in addition to at least 500mL of any crystalloid (0.9% saline, buffered salt solutions such as Plasma-Lyte, Lactated Ringers etc.)